Skip to main content
. 2024 Aug 28;13(17):5117. doi: 10.3390/jcm13175117

Table 8.

Outcomes by follow-up end.

Variable Value
Follow-up from CAR-T cell infusion to end of study, days, median (IQR) 175 (99, 489)
DP by follow-up end 12/38 (31.6)
Time from CAR-T infusion to DP, days, median (IQR) 98 (89, 131)
Exitus by follow-up end 20/38 (52.6)
Cause
Disease progression 12/20 (60.0)
Infection 6/20 (30.0)
Late ICANS 1/20 (5.0)
Unspecified 1/20 (5.0)

Results are n/N (%), except otherwise indicated. DP, disease progression; IQR, interquartile range.